These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33906285)

  • 1. Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea.
    Oh JK; Choi HY; Han M; Jung YS; Lee SJ; Ki M
    Epidemiol Health; 2021; 43():e2021019. PubMed ID: 33906285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates.
    Novakovic D; Cheng AT; Baguley K; Walker P; Harrison H; Soma M; Malloy M; Brotherton JM
    Laryngoscope; 2016 Dec; 126(12):2827-2832. PubMed ID: 27074766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients.
    Tam S; Wu CF; Peng HL; Dahlstrom KR; Sturgis EM; Lairson DR
    Laryngoscope; 2020 May; 130(5):1186-1194. PubMed ID: 31194270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
    Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Recurrent Respiratory Papillomatosis.
    Derkay CS; Bluher AE
    Otolaryngol Clin North Am; 2019 Aug; 52(4):669-679. PubMed ID: 31078306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil.
    Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH
    Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study.
    Novakovic D; Cheng AT; Cope DH; Brotherton JM
    Sex Health; 2010 Sep; 7(3):253-61. PubMed ID: 20719212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age of diagnosis, incidence and prevalence of recurrent respiratory papillomatosis-A South African perspective.
    Seedat RY; Schall R
    Clin Otolaryngol; 2018 Apr; 43(2):533-537. PubMed ID: 29054106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
    Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
    Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
    Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
    JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States.
    Marsico M; Mehta V; Chastek B; Liaw KL; Derkay C
    Sex Transm Dis; 2014 May; 41(5):300-5. PubMed ID: 24722383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study.
    Omland T; Akre H; Vårdal M; Brøndbo K
    Laryngoscope; 2012 Jul; 122(7):1595-9. PubMed ID: 22565595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia.
    Sanchez GI; Jaramillo R; Cuello G; Quintero K; Baena A; O'Byrne A; Reyes AJ; Santamaria C; Cuello H; Arrunategui A; Cortez A; Osorio G; Reina JC; Quint WG; Muñoz N
    Head Neck; 2013 Feb; 35(2):229-34. PubMed ID: 22367608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11.
    Tjon Pian Gi RE; San Giorgi MR; Slagter-Menkema L; van Hemel BM; van der Laan BF; van den Heuvel ER; Dikkers FG; Schuuring EM
    Head Neck; 2015 Nov; 37(11):1625-32. PubMed ID: 24955561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
    Intakorn P; Sonsuwan N
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Office-Based vs Traditional Operating Room Management of Recurrent Respiratory Papillomatosis: Impact of Patient Characteristics and Disease Severity.
    Tatar EÇ; Kupfer RA; Barry JY; Allen CT; Merati AL
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):55-59. PubMed ID: 27658005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent respiratory papillomatosis in northern Sweden: clinical characteristics and practical guidance.
    Loizou C; Laurell G; Arvidsson A; Lindquist D; Nylander K; Olofsson K
    Acta Otolaryngol; 2015; 135(10):1058-64. PubMed ID: 26004132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papilloma virus (HPV) vaccination is associated with reduced number of surgical treatments, an observational study on recurrent respiratory papillomatosis in Northern Sweden.
    Schindele A; Al-Sabtti S; Olofsson K
    Acta Otolaryngol; 2024 Jan; 144(1):71-75. PubMed ID: 38484282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.
    Novakovic D; Cheng ATL; Zurynski Y; Booy R; Walker PJ; Berkowitz R; Harrison H; Black R; Perry C; Vijayasekaran S; Wabnitz D; Burns H; Tabrizi SN; Garland SM; Elliott E; Brotherton JML
    J Infect Dis; 2018 Jan; 217(2):208-212. PubMed ID: 29136168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for adult-onset recurrent respiratory papillomatosis.
    Ruiz R; Achlatis S; Verma A; Born H; Kapadia F; Fang Y; Pitman M; Sulica L; Branski RC; Amin MR
    Laryngoscope; 2014 Oct; 124(10):2338-44. PubMed ID: 24764146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.